Gene · 2804
Papers1,684
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,684
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| [Pharmacokinetic study of anti-human T-cell porcine immunoglobulin combined with cyclosporine A immunosuppressive therapy in patients with severe aplastic anemia]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35680628 | PubTator, text mining | PubMed |
| LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | BMC Cancer | 2022 | 35676659 | PubTator, text mining | PubMed |
| Immunofluorescence-Mediated Detection of Respiratory Virus Infections in Human Airway Epithelial Cultures. | Curr Protoc | 2022 | 35671174 | PubTator, text mining | PubMed |
| Hyper-Reflecting Foci in Multiple Sclerosis Retina Associate With Macrophage/Microglia-Derived Cytokines in Cerebrospinal Fluid. | Front Immunol | 2022 | 35664007 | PubTator, text mining | PubMed |
| Integrating intracellular nanovesicles into integrin trafficking pathways and beyond. | Cell Mol Life Sci | 2022 | 35657500 | PubTator, text mining | PubMed |
| Phase-Separated Subcellular Compartmentation and Related Human Diseases. | Int J Mol Sci | 2022 | 35628304 | PubTator, text mining | PubMed |
| Dual-Functional Antioxidant and Antiamyloid Cerium Oxide Nanoparticles Fabricated by Controlled Synthesis in Water-Alcohol Solutions. | Biomedicines | 2022 | 35625679 | PubTator, text mining | PubMed |
| Pure laparoscopic versus open left lateral sectionectomy for hepatocellular carcinoma: A propensity score matching analysis. | Ann Hepatobiliary Pancreat Surg | 2022 | 35607809 | PubTator, text mining | PubMed |
| The role of re-resection in recurrent hepatocellular carcinoma. | Langenbecks Arch Surg | 2022 | 35599252 | PubTator, text mining | PubMed |
| Phosphoinositides as membrane organizers. | Nat Rev Mol Cell Biol | 2022 | 35589852 | PubTator, text mining | PubMed |
| Analysis of changes in the proteomic profile of porcine corpus luteum during different stages of the oestrous cycle: effects of PPAR gamma ligands. | Reprod Fertil Dev | 2022 | 35577556 | PubTator, text mining | PubMed |
| Sonic Hedgehog Signaling in Cerebellar Development and Cancer. | Front Cell Dev Biol | 2022 | 35573667 | PubTator, text mining | PubMed |
| Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis. | Cells | 2022 | 35563790 | PubTator, text mining | PubMed |
Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application. | Trials | 2022 | 35546412 | PubTator, text mining | PubMed |
| A comparison between thoracic epidural analgesia and rectus sheath catheter analgesia after open midline major abdominal surgery: randomized clinical trial. | BJS Open | 2022 | 35543263 | PubTator, text mining | PubMed |
| MTCL2 promotes asymmetric microtubule organization by crosslinking microtubules on the Golgi membrane. | J Cell Sci | 2022 | 35543016 | PubTator, text mining | PubMed |
| Rab33b-exocyst interaction mediates localized secretion for focal adhesion turnover and cell migration. | iScience | 2022 | 35521520 | PubTator, text mining | PubMed |
| A kinesin-1 variant reveals motor-induced microtubule damage in cells. | Curr Biol | 2022 | 35504282 | PubTator, text mining | PubMed |
Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol. | BMC Cancer | 2022 | 35501736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2804/papers?page=16